dihexa pubmed SPRAY : COA Tested Research spray : NeuroLabs Peptides Dihexa | Rize Up Medical

Front Pharmacol 9:1181 Gao Y, Li J, Wu L, Zhou C, Wang Q, Li X, Zhou M, Wang H (2016) Tetrahydrocurcumin provides neuroprotection in rats after traumatic brain injury: autophagy and the PI3K/AKT pathways as a potential mechanism

Risk of Hypoglycemia: While cagrilintide targets mechanisms that help regulate blood sugar, its specific risk profile for hypoglycemia (dangerously low blood sugar levels) will need to be clarified as research continues

The risk of elevated homocysteine is even higher in those with low B12

Retatrutide 40mg (R&D Only) Retatrutide research peptide, 40mg vial

Professor Muresanus research contributions include: Principal investigator for the CARS trial (Cerebrolysin and Recovery After Stroke), the largest randomized controlled trial examining functional outcomes Lead investigator for CAPTAIN trials evaluating Cerebrolysin in traumatic brain injury populations Extensive research on neurotrophic factor signaling and neuroprotective mechanisms Development of multimodal therapeutic strategies combining Cerebrolysin with rehabilitation Investigations of dose-response relationships and optimal treatment protocols across neurological conditions His work has been instrumental in advancing understanding of peptidergic neuroprotection, though clinical translation challenges remain a focus of ongoing investigation